黄羽棠｜重庆医科大学｜学者主页

期刊论文

2026

Targeting intratumoral Streptococcus mitis suppresses the progression of esophageal squamous cell carcinoma

Ruijin Lu, Ju Zhu, Qinghua Song, Yutang Huang, Xue Zhou, Weiqin Du, Chunjie Wen, Weifeng Xia, Qingchen Wu, Lanxiang Wu

Science China Life Sciences

DOI

2026

GPNMB-ECD drives acquired resistance to osimertinib in NSCLC via inducing tumor cell cytoskeletal reorganization

Min Zhang, Jia-Qi Wang, X L Yang, W.T. Liu, Yutang Huang, Chunjie Wen, Dan Chen, Lanxiang Wu

Cellular & Molecular Biology Letters

DOI

2026

Biomimetic fusion nanosystem from ginger exosomes and tumor cell membranes: boosting PLK1-targeted therapy in BRCA-heterogeneous HGSOC

Xue Zhou, Yutang Huang, Chenyi Li, Wenlu Mo, Wei-Feng Xia, Ruiqing Du, Lan-Xiang Wu, Hongbo Zhao

Journal of Nanobiotechnology

DOI

2025

连接桥粒斑珠蛋白促进高级别浆液性卵巢癌恶性进展的机制

黄羽棠，杜炜钦，袁冬，雷甜甜，温纯洁，吴兰香

《实用医学杂志》

2025

瘤内Gemella haemolysans对增强食管鳞状细胞癌荷瘤小鼠新辅助化学免疫治疗疗效的研究

宋清华，卢睿瑾，黄羽棠，陈力，吴兰香

《重庆医科大学学报》

DOI

2025

Prognostic Value and Immunological Role of CBX7 in Lung Adenocarcinoma

Yang Li, Yutang Huang, Wenlu Mo, Lanxiang Wu, Chunjie Wen

Current Molecular Medicine

DOI

2024

Utility of patient-derived xenografts to evaluate drug sensitivity and select optimal treatments for individual non-small-cell lung cancer patients

Xiaoqing Wang, Ju Zhu, Lingling Li, Qilin Zhao, Yutang Huang, Chunjie Wen, Dan Chen, Lanxiang Wu

Molecular Medicine

DOI

2024

Cancer‐associated fibroblast‐derived colony‐stimulating factor 2 confers acquired osimertinib resistance in lung adenocarcinoma via promoting ribosome biosynthesis

Yutang Huang, Xiaoqing Wang, Chunjie Wen, J.H. Wang, Hong‐Hao Zhou, Lanxiang Wu

MedComm

DOI

2024

CircMYBL1 suppressed acquired resistance to osimertinib in non-small-cell lung cancer

Yaji Li, Nan Wang, Yutang Huang, Shuai He, Meihua Bao, Chunjie Wen, Lanxiang Wu

Cancer Genetics

DOI

2022

Lnc-TMEM132D-AS1 as a potential therapeutic target for acquired resistance to osimertinib in non-small-cell lung cancer

Nan Wang, Qilin Zhao, Yutang Huang, Chunjie Wen, Yaji Li, Meihua Bao, Lanxiang Wu

Molecular Omics

DOI

2022

CircSETD3 mediates acquired resistance to gefitinib in non-small lung cancer cells by FXR1/ECT2 pathway

Chunjie Wen, Yaji Li, Yutang Huang, Nan Wang, Shuai He, Meihua Bao, Hong‐Hao Zhou, Lanxiang Wu

The International Journal of Biochemistry & Cell Biology

DOI

2020

circSETD3 Contributes to Acquired Resistance to Gefitinib in Non-Small-Cell Lung Cancer by Targeting the miR-520h/ABCG2 Pathway

Yutang Huang, Yi Dai, Chunjie Wen, Shuai He, Jingjing Shi, Dezhang Zhao, Lanxiang Wu, Hong‐Hao Zhou

Molecular Therapy — Nucleic Acids

DOI

2020

Genome-wide identification and characterization of long non-coding RNAs involved in acquired resistance to gefitinib in non-small-cell lung cancer

Jingjing Shi, Yutang Huang, Chunjie Wen, Shuai He, Lanxiang Wu, Hong‐Hao Zhou

Computational Biology and Chemistry

DOI

2020

Screening Circular RNAs Related to Acquired Gefitinib Resistance in Non-small Cell Lung Cancer Cell Lines

Chunjie Wen, Ge Xu, Shuai He, Yutang Huang, Jingjing Shi, Lanxiang Wu, Hong‐Hao Zhou

Journal of Cancer

DOI

2019

Long-term exposure of 4-hydroxyestradiol induces the cancer cell characteristics via upregulating CYP1B1 in MCF-10A cells

Lan-Xiang Wu, Bin Wang, Ge Xu, Yutang Huang, Chun-Jie Wen, Hong-hao Zhou

Toxicology Mechanisms and Methods

DOI

2018

Ct-OATP1B3基因对人卵巢癌细胞迁移、侵袭与增殖调控的研究

黄家凤，黄羽棠，代谊，师晶晶，温纯洁，吴兰香，周宏灏

《中国细胞生物学学报》

2018

ABCC10 Plays a Significant Role in the Transport of Gefitinib and Contributes to Acquired Resistance to Gefitinib in NSCLC

Hongbo Zhao, Yutang Huang, Jingjing Shi, Yi Dai, Lanxiang Wu, Hong‐Hao Zhou

Frontiers in Pharmacology

DOI

2017

吉非替尼获得性耐药非小细胞肺癌细胞中差异表达环状RNA分析

代谊，黄羽棠，黄家凤，温纯洁，周宏灏，吴兰香

《肿瘤》

2017

Differential expression of circular RNAs in gefitinib-acquired resistant non-small cell lung cancer cells

Yi Dai, Yutang Huang, Jia-feng Huang, Chun-Jie Wen, Hong-Hao Zhou, Lan-Xiang Wu

预印本

2023

Lnc-CSRNP3 Confers Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer by Promoting Ribosome Biosynthesis

Yutang Huang, Chunjie Wen, Ying Zhang, Shuai He, Jing-chan Wang, Yaji Li, Nan Wang, Hong‐Hao Zhou

SSRN Electronic Journal

DOI

黄羽棠

精选作品

期刊论文

Targeting intratumoral Streptococcus mitis suppresses the progression of esophageal squamous cell carcinoma

GPNMB-ECD drives acquired resistance to osimertinib in NSCLC via inducing tumor cell cytoskeletal reorganization

Biomimetic fusion nanosystem from ginger exosomes and tumor cell membranes: boosting PLK1-targeted therapy in BRCA-heterogeneous HGSOC

连接桥粒斑珠蛋白促进高级别浆液性卵巢癌恶性进展的机制

瘤内Gemella haemolysans对增强食管鳞状细胞癌荷瘤小鼠新辅助化学免疫治疗疗效的研究

Prognostic Value and Immunological Role of CBX7 in Lung Adenocarcinoma

Utility of patient-derived xenografts to evaluate drug sensitivity and select optimal treatments for individual non-small-cell lung cancer patients

Cancer‐associated fibroblast‐derived colony‐stimulating factor 2 confers acquired osimertinib resistance in lung adenocarcinoma via promoting ribosome biosynthesis

CircMYBL1 suppressed acquired resistance to osimertinib in non-small-cell lung cancer

Lnc-TMEM132D-AS1 as a potential therapeutic target for acquired resistance to osimertinib in non-small-cell lung cancer

CircSETD3 mediates acquired resistance to gefitinib in non-small lung cancer cells by FXR1/ECT2 pathway

circSETD3 Contributes to Acquired Resistance to Gefitinib in Non-Small-Cell Lung Cancer by Targeting the miR-520h/ABCG2 Pathway

Genome-wide identification and characterization of long non-coding RNAs involved in acquired resistance to gefitinib in non-small-cell lung cancer

Screening Circular RNAs Related to Acquired Gefitinib Resistance in Non-small Cell Lung Cancer Cell Lines

Long-term exposure of 4-hydroxyestradiol induces the cancer cell characteristics via upregulating CYP1B1 in MCF-10A cells

Ct-OATP1B3基因对人卵巢癌细胞迁移、侵袭与增殖调控的研究

ABCC10 Plays a Significant Role in the Transport of Gefitinib and Contributes to Acquired Resistance to Gefitinib in NSCLC

吉非替尼获得性耐药非小细胞肺癌细胞中差异表达环状RNA分析

Differential expression of circular RNAs in gefitinib-acquired resistant non-small cell lung cancer cells

预印本

Lnc-CSRNP3 Confers Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer by Promoting Ribosome Biosynthesis

研究方向